Transforming growth factor-alpha -induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation
Open Access
- 15 February 1997
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 16 (4) , 750-759
- https://doi.org/10.1093/emboj/16.4.750
Abstract
The endothelial cell‐specific mitogen vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) represents a central regulator of cutaneous angiogenesis. Increased VPF/VEGF expression has recently been reported in psoriatic skin and healing wounds, both conditions in which transforming growth factor‐α (TGFα) and its ligand, the epidermal growth factor receptor, are markedly up‐regulated. Since TGFα strongly induces VPF/VEGF synthesis in keratinocytes, TGFα‐mediated VPF/VEGF expression is likely to play a significant role in the initiation and maintenance of increased vascular hyperpermeability and hyperproliferation in skin biology. The objectives of the present studies were to determine the molecular mechanisms responsible for TGFα‐induced transcriptional activation of the VPF/VEGF gene. We have identified a GC‐rich TGFα‐responsive region between −88 bp and −65 bp of the VPF/VEGF promoter that is necessary for constitutive and TGFα‐inducible transcriptional activation. In electrophoretic mobility shift assays, this region binds Sp1‐dependent protein complexes constitutively and an additional TGFα‐inducible protein complex that is distinct from Sp1 protein. Both AP‐2 and Egr‐1 transcription factors were detected as components of the TGFα‐inducible protein complex in supershift EMSA studies. In co‐transfection studies, an AP‐2 but not an Egr‐1 expression vector activated VPF/VEGF transcription, thus indicating that AP‐2 protein is functionally important in TGFα‐induced VPF/VEGF gene expression. By clarifying regulatory mechanisms that are critical for angiogenic processes in the skin, these studies may form the basis for new therapeutic strategies to modulate VPF/VEGF expression in cutaneous inflammation and wound healing.Keywords
This publication has 57 references indexed in Scilit:
- Molecular Regulation of Angiogenesis in the SkinJournal of Investigative Dermatology, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Evaluation of Cytokines in Donor Site Wound FluidsScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitroBiochemical and Biophysical Research Communications, 1992
- Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.The Journal of Experimental Medicine, 1992
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene familyBiochemical and Biophysical Research Communications, 1989
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.The Journal of cell biology, 1988